• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Supernus Pharmaceuticals, Inc. - Common Stock (NQ:SUPN)

    51.24 +1.98 (+4.02%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 587,253
    Open 50.15
    Bid (Size) 36.63 (100)
    Ask (Size) 56.00 (200)
    Prev. Close 49.26
    Today's Range 49.90 - 51.41
    52wk Range 29.16 - 57.65
    Shares Outstanding 53,145,884
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Regencell Bioscience (RGC) Stumbles into 2026: 8% Year-End Slide Sparks Technical Caution
    As the final bells rang on the 2025 trading year, investors in Regencell Bioscience (NASDAQ: RGC) were met with a sobering reality check. The Hong Kong-based biotech firm, which has enjoyed a meteoric... 
    Via MarketMinute
    News headline image
    3 Low-Volatility Stocks We’re Skeptical Of
    Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets. 
    Via StockStory

    Performance

    YTD
    +3.6%
    +3.6%
    1 Month
    +8.7%
    +8.7%
    3 Month
    +6.6%
    +6.6%
    6 Month
    +59.7%
    +59.7%
    1 Year
    +38.3%
    +38.3%

    More News

    Read More
    News headline image
    3 of Wall Street’s Favorite Stocks That Concern Us
    Via StockStory
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    News headline image
    A Preview Of Supernus Pharmaceuticals's Earnings ↗
    Via Benzinga
    News headline image
    Optimism Flows From Pot To Psychedelics: Atai Beckley, Supernus Stocks Rise After Analyst Flags Positive Tailwinds From Trump’s Marijuana Order ↗
    Via Stocktwits
    Topics Cannabis ETFs Government
    News headline image
    Supernus Stock Is Up 31% This Past Year but Still 20% Below 2018 Highs as One Fund Scales Back ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    1 Cash-Heavy Stock for Long-Term Investors and 2 We Turn Down
    Via StockStory
    News headline image
    3 Stocks Under $50 That Concern Us
    Via StockStory
    News headline image
    3 Unprofitable Stocks We Find Risky
    Via StockStory
    News headline image
    Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference
    From Supernus Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    1 Healthcare Stock Worth Your Attention and 2 Facing Headwinds
    Via StockStory
    Topics Stocks
    News headline image
    Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference
    From Supernus Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Branded Pharmaceuticals Stocks Q3 Results: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN)
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Why This Fund Trimmed a $161 Million Travere Position After a 100% Rally ↗
    Via The Motley Fool
    News headline image
    3 Russell 2000 Stocks Walking a Fine Line
    Via StockStory
    News headline image
    Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London
    From Supernus Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    5 Must-Read Analyst Questions From Supernus Pharmaceuticals’s Q3 Earnings Call
    Via StockStory
    Topics Earnings
    News headline image
    Why Supernus Pharmaceuticals (SUPN) Shares Are Trading Lower Today
    Via StockStory
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    SUPN Q3 Deep Dive: Growth Drivers Offset By Supply Constraints and Integration Costs
    Via StockStory
    Topics Supply Chain
    News headline image
    Supernus Pharmaceuticals (NASDAQ:SUPN) Surprises With Strong Q3
    Via StockStory
    News headline image
    Supernus Announces Third Quarter 2025 Financial Results
    From Supernus Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Spotting Winners: Royalty Pharma (NASDAQ:RPRX) And Branded Pharmaceuticals Stocks In Q2
    Via StockStory
    Topics Artificial Intelligence Intellectual Property

    Frequently Asked Questions

    Is Supernus Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Supernus Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Supernus Pharmaceuticals, Inc. - Common Stock trade on?
    Supernus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock is SUPN on the Nasdaq Stock Market
    What is the current price of Supernus Pharmaceuticals, Inc. - Common Stock?
    The current price of Supernus Pharmaceuticals, Inc. - Common Stock is 51.24
    When was Supernus Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Supernus Pharmaceuticals, Inc. - Common Stock was at 01/07/26 04:00 PM ET
    What is the market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock is 2.72B
    How many shares of Supernus Pharmaceuticals, Inc. - Common Stock are outstanding?
    Supernus Pharmaceuticals, Inc. - Common Stock has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.